Skip to content
StockMarketAgent
Direct answer
DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The base case assumes steady, low-growth cash generation with gradual GAAP margin improvement. Fair value range: low $20.8, high $36.5, with mid-point at $28.6.
Stock analysis

DOCU fair value $21–$36

By StockMarketAgent.AI team· supervised by
분석일: 2026-05-10다음 업데이트: 2026-08-10Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
주가
$47.90
▼ -19.30 (-40.29%)
공정 가치
$29
$21–$36
등급
매도
confidence 80/100
상승 여력
-40.3%
upside to fair value
안전 마진
$24.31
MoS level · 15%
시가총액
$9.3B
P/E fwd 9.5
영어 원본으로 대체KO
번역하는 동안 영어 원본을 표시 중
이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

§1 개요

  • Synthesized fair value is $28.60, representing a massive discount to current trading levels.
  • GAAP metrics are severely penalized by stock-based compensation running near 19% of revenue.
  • Street internal valuation cross-checks improperly anchors on non-GAAP figures that mask true shareholder dilution.
  • Growth has structurally decelerated into the single digits as the core market matures.
Fair value
$29
Margin of safety
-67.5%
Confidence
80/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$47.90Price
Low $20.81
Mid $28.60
High $36.46

DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The base case assumes steady, low-growth cash generation with gradual GAAP margin improvement.

  • Switching Costs
    Switching Costs
  • Network Effects
    Network Effects
  • Cycle upside
    Enterprise digitization expands beyond simple signatures into full contract lifecycle management.

§2 베어 케이스

A rapid acceleration in e-signature commoditization drives intense pricing pressure, collapsing top-line growth to near zero while GAAP margins remain structurally impaired by relentless stock-based compensationStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. dilutionDilutionThe increase in share count over time, typically driven by SBC vesting, equity issuance, or M&A in stock. Reduces existing shareholders' per-share claim on cash flows..

이 논제가 무너지는 경로

Severe Pricing Compression

· Medium

Enterprise customers aggressively negotiate e-signature renewals as bundled alternatives like Adobe become good enough, collapsing gross margins.

FV impact
-30%
Trigger
12-24 months

IAM Adoption Failure

· High

The Intelligent Agreement Management platform fails to gain traction among enterprise clients, limiting growth entirely to the saturated core e-signature market.

FV impact
-25%
Trigger
24-36 months

SBC Spiral

· Medium

Management fails to reign in stock-based compensation, keeping it near 20% of revenue. Share buybacks prove insufficient to prevent heavy dilution as free cash flow plateaus.

FV impact
-40%
Trigger
24-48 months
모니터링할 조기 경보 신호
지표현재트리거 임계값
Consecutive quarters of net revenue retention falling below 100%.MonitorDeterioration versus the report thesis
SBC as a percentage of revenue expands back above 20%.MonitorDeterioration versus the report thesis
Unadjusted GAAP operating margins decline year-over-year.MonitorDeterioration versus the report thesis
Total billings growth drops into negative territory.MonitorDeterioration versus the report thesis
Free cash flow generation materially trails GAAP net income due to working capital deterioration.MonitorDeterioration versus the report thesis

§3 재무 이력

손익계산서 — 최근 6기
항목T−0T−1T−2T−3CAGR
기간2023-01-312024-01-312025-01-312026-01-31Trend
매출$2.52B$2.76B$2.98B$3.22B+8.6%
매출총이익$1.98B$2.19B$2.36B$2.56B+8.9%
영업이익$-59.7M$62.0M$229.6M$298.6M
순이익$-97.5M$74.0M$1.07B$309.1M
EPS (희석)$-0.49$0.36$5.08$1.48
EBITDA$2.8M$195.6M$357.3M$466.0M+452.5%
R&D$480.6M$539.5M$588.5M$665.0M+11.4%
판관비$1.56B$1.59B$1.54B$1.59B+0.7%

품질 점수

Piotroski F-스코어
6 / 9
0–9 품질 종합
Altman Z-스코어
2.68
파산 위험 (>3 안전)
OCF / 순이익
3.77×
>1은 이익의 질이 높음을 의미
회계 품질 게이트
Pass
섹터 조정 게이트
ROIC
13.1%
투하자본수익률
섹션 3

Numbers analysis

현금 흐름

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

자본 배분

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

개인 구독자 — §4부터11개 섹션 더

전체 분석 읽기 — 11개 섹션 더.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

모든 커버 종목에 대한 전체 보고서
24개월 등급 아카이브
관심 목록 브리핑 + 등급 변경 알림
모든 언어로 PDF + DOCX 내보내기
무료 체험 시작
언제든지 취소 가능.
SCENARIOS FAQ

DOCU scenarios questions

  1. Each scenario for DOCU (DOCU) carries a five-year price target, an explicit set of assumptions (growth, terminal multiple, margin path), and a probability weight calibrated against current visibility.
FAQ

DOCU — frequently asked questions

  1. Based on our latest analysis, DOCU looks meaningfully overvalued. The current price is $47.9 versus a composite fair-value midpoint of $28.6 (range $20.8–$36.5), which implies roughly 40.3% downside to the midpoint.
Related coverage

Names readers of DOCU also follow

Same archetype: mature-compounder